Use of phenytoin for the long-term treatment of partial seizures: Results of a survey conducted during the 2004 meeting of the American Academy of Neurology
- PMID: 24672128
- PMCID: PMC3964568
- DOI: 10.1016/j.curtheres.2005.08.004
Use of phenytoin for the long-term treatment of partial seizures: Results of a survey conducted during the 2004 meeting of the American Academy of Neurology
Abstract
Background: Epilepsy is a chronic disorder that typically requires lifelongpharmacologic treatment. The choice of an antiepileptic drug (AED), therefore, requires careful consideration of efficacy and tolerability. However, the majority of patients with new-onset seizures are initially treated by physicians in the emergency department (ED) or by non-ED physicians (primary care physicians or internists), with phenytoin being the most common AED prescribed for initial therapy, and the long-term adverse effects of AEDs are often overlooked.
Objective: The aim of this survey was to examine the perspectives of neurologistsand epileptologists concerning initial therapies prescribed by ED physicians and non-ED physicians for newly diagnosed partial seizures, particularly phenytoin, and the suitability of these therapies for long-term management of the disease.
Methods: A computerized survey was conducted during the 2004 AmericanAcademy of Neurology meeting. The survey consisted of 10 questions concerning the use of AEDs in the initial and long-term treatment of newly diagnosed partial seizures.
Results: The responses of 268 practitioners were analyzed. Survey participants indicated that 71% of patients referred to them by ED physicians were receiving phenytoin, whereas 59% of patients referred to them by non-ED physicians were receiving phenytoin. Seventy-six percent of survey participants responded that they would switch a patient having partial seizures referred from the ED to another AED. Seventy-eight percent indicated that they did not believe that the medications being received by patients with newly diagnosed partial seizures in the ED were suitable for long-term epilepsy treatment.
Conclusion: Although appropriate treatment might vary in the acute and chronic settings, and phenytoin is used as a primary agent for acute treatment of seizures presenting in the ED, the results of the present survey suggest a discrepancy between the medications that primary care and ED physicians prescribe for newly diagnosed partial seizures and those that specialists prescribe for long-term therapy.
Keywords: antiepileptic drugs; bone; bone mineral density; epileptologist; neurologist; partial epilepsy; phenytoin; survey.
References
-
- Meador K.J., Gilliam F.G., Kanner A.M., Pellock J.M. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav. 2001;2:SS1–SS17. - PubMed
-
- Devinsky 0., Cramer J. Safety and efficacy of standard and new antiepileptic drugs. Neurology. 2000;55(Suppl 3):S5–S10. - PubMed
-
- Pellock J.M., Smith M.C., Cloyd J.C. Extended-release formulations: Simplifying strategies in the management of antiepileptic drug therapy. Epilepsy Behav. 2004;5:301–307. - PubMed
-
- Smith M.C., Buelow J.M. Epilepsy. Dis Mon. 1996;42:729–827. - PubMed
-
- Pugh M.J., Cramer J., Knoefel J. Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy. J Am Geriatr Soc. 2004;52:417–422. - PubMed
LinkOut - more resources
Full Text Sources
